When is a residue not a residue?

Residues of veterinary products in food animals have been the subject of much debate in recent years. This paper attempts to define and classify what is meant by the term 'residue' and to discuss the toxicological significance of various types of residues and how they may be controlled to ensure that no hazard results to consumers.     

Pulmonary Clearance of Bacillus subtilis Spores in Pigs

The pulmonary clearance rate of Bacillus subtilis was determined in ten pigs (23-39 kg) exposed simultaneously for 15 minutes to an aerosol generated by an ultrasonic nebulizer. Two pigs were killed at each interval of zero, two, four, eight and 12 hours and the concentrations of B. subtilis in lungs (all lobes), dorsal and ventral nasal turbinates, trachea, pharyngeal and bronchial lymph nodes were determined. The mean percent (± standard error) pulmonary clearance of B.subtilis was 54.2±11.7, 53.0±11.8, 77.4±5.2 and 88.1±3.7 at two, four, eight and 12 hours, respectively. The numbers of B. subtilis retained in the posterior (caudal and accessory) lobes at zero time were significantly greater than those in the anterior (cranial and middle) lobes (P<0.05). However, by 12 hours postinoculation the numbers of organisms retained in the two regions did not differ significantly (P>0.05). The mean percentage of B. subtilis retained by the turbinates, trachea, pharyngeal and bronchial lymph nodes varied between pigs at each time interval, but was usually less than that retained by the lungs.

It was concluded that deposition of B. subtilis spores took place in all parts of the respiratory tract when pigs were exposed to aerosols and that the spores were progressively cleared by the normal lung.

     

Haemophilus somnus Infections II. A Canadian Field Trial of a Commercial Bacterin: Clinical and Serological Results

To evaluate the efficacy of a Haemophilus somnus bacterin a total of 1114 beef calves or yearling bulls were used in the province of Saskatchewan. The six herds were included in a vaccination trial in which the vaccine was administered subcutaneously in one or two doses. The prevalence of H. somnus in nasal swabs of these animals at the time of the initial vaccination was 0.35% Postvaccination information on morbidity and mortality for a four month period was requested from the five ranches where there were nonvaccinated control calves. Postvaccination outbreaks of infectious thromboembolic meningoencephalitis occurred in two of these herds and, although the numbers were limited, there was a trend to reduced morbidity and mortality in the vaccinated animals compared to controls. Seroconversion rates, as determined by the complement fixation test, in the six herds were 28.3% for control calves, 57% for animals vaccinated once and 80.3% for animals vaccinated twice. On the basis of these results the bacterin was considered to be sufficiently efficacious to warrant its further evaluation under field conditions.     

Infectious bovine keratoconjunctivitis II. Antibodies in lacrimal secretions of cattle naturally or experimentally infected with Moraxella bovis.

One or both eyes of 20 calves were inoculated one or more time with variou(s combinations of microorganism (live oor killed Moraxella bovis, infectious bovine rhinotracheitis virus, bovine adenovirus, bovine parainfluenza-3 virus and Mycoplasma bovoculi) by conjunctival instillation or direct inoculation of the conjunctivea or cornea. The eyes of all the calves received natural or artificial ultraviolet irradiation. Neither the adenovirus nor parainfluenza-3 virus became established in the eye or produced keratoconjunctivitis. Both M. bovis and infectious bovine rhinotracheitis virus became established in the bovine eye and produced disease. Subconjunctival or intracorneal inoculation of M. bovis caused a severe disease, simulating natural infectious bovine keratoconjunctivitis. Only the intracorneal inoculation of mycoplasma produced severe keratoconjunctivits. Eyes that on initial exposure to M. bovis became severly inflamed were more resistant to a second or third exposure to M. bovis, presumably by enhanced local defence mechanisms.     

ULTRASONIC DETECTION OF SPLENIC NECROSIS IN THE DOG

Ultrasonographic findings of splenic infarction and necrosis in three dogs are presented. Two previously unreported ultrasonographic patterns are identified: (1) Focal, hypoechoic or isoechoic, circular, wellmarginated nodular masses with peripheral lesions causing deformation of the splenic margin. (2) Diffuse hypoechoic or heteroechoic coarse/"lacy" parenchymal pattern with no deformation of margin. The presence of gas within the splenic parenchyma of one dog was detected by both radiography and ultrasonography. Ultrasonographic patterns of splenic infarction in both man and the dog are discussed     

A systematic survey of loss-of-function variants in human protein-coding genes

Genome-sequencing studies indicate that all humans carry many genetic variants predicted to cause loss of function (LoF) of protein-coding genes, suggesting unexpected redundancy in the human genome. Here we apply stringent filters to 2951 putative LoF variants obtained from 185 human genomes to determine their true prevalence and properties. We estimate that human genomes typically contain ~100 genuine LoF variants with ~20 genes completely inactivated. We identify rare and likely deleterious LoF alleles, including 26 known and 21 predicted severe disease-causing variants, as well as common LoF variants in nonessential genes. We describe functional and evolutionary differences between LoF-tolerant and recessive disease genes and a method for using these differences to prioritize candidate genes found in clinical sequencing studies.     

Detection of Aphanomyces invadans and epizootic ulcerative syndrome in the Murray‐Darling drainage

Epizootic ulcerative syndrome was diagnosed, and the presence of Aphanomyces invadans confirmed, from an outbreak of clinical disease in wild‐caught bony bream (Nematalosa erebi) from the Darling River near Bourke, in New South Wales, Australia, during 2008. This confirms a significant extension of the agent beyond its historical range.